 Inflammation in the subcutis following vaccination is considered to be a risk factor in the development of VAS, and vaccines containing aluminum were found to produce more inflammation.Furthermore, particles of aluminum adjuvant have been discovered in tumor macrophages.In addition, individual genetic characteristics can also contribute to these injection-site sarcomas.